Our comparative studies of
Ascaris and mammalian hosts revealed, for the first time, the occurrence of a
de novo pyrimidine biosynthetic pathway in a helminth parasite, together with the very low and unstable activity of carbamoyl-phosphate synthetase II (CPS II), the first, rate-limiting and regulatory enzyme of the pathway. A prominent feedback inhibition by UDP is characteristic of
Ascaris and trypanosomatid CPS II, while UMP and UTP are the most potent inhibitors against
Escherichia and mammalian enzyme, respectively. Amino acid residues at UMP-, UDP-, and UTP-binding sites are lysine (hydrophilic;
Escherichia CPS II), glutamine (trypanosomatid CPS II), and tryptophan (hydrophobic;mammalian CPS II), respectively. Another comparative study showed a significant correlation between the CPS II activities and a series of Morris hepatomas with increasing growth rates, implying that the enzyme activity is linked with tumor transformation and progression.
In
Trypanosoma cruzi and
Leishmania mexicana, intracellular protozoan parasites classified as trypanosomatids, all 6 enzymes of
de novo pyrimidine biosynthesis are encoded by a compact
pyr gene cluster containing
pyr1-pyr6;the order of these genes from the 5 -terminus is :
pyr1-pyr3-pyr6/5 (fused gene) -
pyr2-pyr4. This is the first report for the eukaryotic organism possessing such a unique gene cluster of all the genes involved in the metabolic pathway. The trypanosomatid
pyr gene cluster may provide a basis for nucleic acid-precursor synthesis, highly probably supporting protozoan growth and eventually causing pathogenicity.
T. cruzi causes a marked inhibition of apoptosis in the infected human cell, resulting in parasite survival and thus likely leading to the Chagas' disease. The pathogen up-regulates and exploits cFLIP, only one inhibitor known to specifically inhibit Fas-mediated apoptosis in mammalian cells. This up-regulation or accumulation of cFLIP results from the blockage of Itch, a ubiquitin ligase, of host origin;that is,
T. cruzi infection markedly decreases the interaction of the host cFLIP and Itch, yielding a lowered proteasomal degradation of cFLIP. In contrast to some viruses carrying their own genes for inhibition of host cell apoptosis, trypanosomes exploit the host molecules, cFLIP and Itch, for their survival, a unique mechanism employed by a eukaryotic intracellular microbial pathogen. Further, we found an important effector molecule SPRING (secretory protein with a RING finger domain) in
T. cruzi, but neither in
Trypanosoma brucei nor in
Leishmania major. T. cruzi secretes SPRING;the signal sequence-deleted SPRING is localized in the host cell nucleus, has a ubiquitin ligase activity and interacts with a number of host proteins. These findings indicate that SPRING may affect and modify the host proteins. Studies of trypanosomatid effector molecules and host-cell interactant molecules may be promising approaches for deepening our understanding of
T. cruzi and Chagas' disease.
View full abstract